Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: PYRIDINES - THERAPEUTIC USE , . Treffer: 18

2018

Pichler, G; Pux, C; Babeluk, R; Hermann, B; Stoiser, E; De Campo, A; Grisold, A; Zollner-Schwetz, I; Krause, R; Schippinger, W MRSA prevalence rates detected in a tertiary care hospital in Austria and successful treatment of MRSA positive patients applying a decontamination regime with octenidine.
Eur J Clin Microbiol Infect Dis. 2018; 37(1):21-27 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2017

Berry, V; Basson, L; Bogart, E; Mir, O; Blay, JY; Italiano, A; Bertucci, F; Chevreau, C; Clisant-Delaine, S; Liegl-Antzager, B; Tresch-Bruneel, E; Wallet, J; Taieb, S; Decoupigny, E; Le Cesne, A; Brodowicz, T; Penel, N REGOSARC: Regorafenib versus placebo in doxorubicin-refractory soft-tissue sarcoma-A quality-adjusted time without symptoms of progression or toxicity analysis.
Cancer. 2017; 123(12):2294-2302 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2016

Lindau, A; Härdtner, C; Hergeth, SP; Blanz, KD; Dufner, B; Hoppe, N; Anto-Michel, N; Kornemann, J; Zou, J; Gerhardt, LM; Heidt, T; Willecke, F; Geis, S; Stachon, P; Wolf, D; Libby, P; Swirski, FK; Robbins, CS; McPheat, W; Hawley, S; Braddock, M; Gilsbach, R; Hein, L; von zur Mühlen, C; Bode, C; Zirlik, A; Hilgendorf, I Atheroprotection through SYK inhibition fails in established disease when local macrophage proliferation dominates lesion progression.
Basic Res Cardiol. 2016; 111(2):20-20 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Mir, O; Brodowicz, T; Italiano, A; Wallet, J; Blay, JY; Bertucci, F; Chevreau, C; Piperno-Neumann, S; Bompas, E; Salas, S; Perrin, C; Delcambre, C; Liegl-Atzwanger, B; Toulmonde, M; Dumont, S; Ray-Coquard, I; Clisant, S; Taieb, S; Guillemet, C; Rios, M; Collard, O; Bozec, L; Cupissol, D; Saada-Bouzid, E; Lemaignan, C; Eisterer, W; Isambert, N; Chaigneau, L; Cesne, AL; Penel, N Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Oncol. 2016; 17(12):1732-1742
Web of Science PubMed FullText FullText_MUG

 

2015

Brodowicz, T; Liegl-Atzwager, B; Tresch, E; Taieb, S; Kramar, A; Gruenwald, V; Vanseymortier, M; Clisant, S; Blay, JY; Le Cesne, A; Penel, N Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial.
BMC Cancer. 2015; 15(4):127-127 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Ulrich, C; Kluschke, F; Patzelt, A; Vandersee, S; Czaika, VA; Richter, H; Bob, A; Hutten, Jv; Painsi, C; Hüge, R; Kramer, A; Assadian, O; Lademann, J; Lange-Asschenfeldt, B Clinical use of cold atmospheric pressure argon plasma in chronic leg ulcers: A pilot study.
J Wound Care. 2015; 24(5): 202- 203.
Web of Science PubMed FullText FullText_MUG

 

2014

Rudashevskaya, EL; Stockner, T; Trauner, M; Freissmuth, M; Chiba, P Pharmacological correction of misfolding of ABC proteins.
Drug Discov Today Technol. 2014; 12(12):e87-e94 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

2013

Bareck, E; Ba-Ssalamah, A; Brodowicz, T; Eisterer, W; Häfner, M; Högenauer, C; Kastner, U; Kühr, T; Längle, F; Liegl-Atzwanger, B; Schoppmann, SF; Widmann, G; Wrba, F; Zacherl, J; Ploner, F; Austrian representatives of Medical and Surgical Oncology, Pathology, Radiology, Nuclear Medicine, Gastroenterology, and Laboratory Medicine Gastrointestinal stromal tumors: diagnosis, therapy and follow-up care in Austria.
Wien Med Wochenschr. 2013; 163(5-6):137-152
PubMed FullText FullText_MUG

 

2012

Halbmayer, WM; Weigel, G; Quehenberger, P; Tomasits, J; Haushofer, AC; Aspoeck, G; Loacker, L; Schnapka-Koepf, M; Goebel, G; Griesmacher, A Interference of the new oral anticoagulant dabigatran with frequently used coagulation tests.
Clin Chem Lab Med. 2012; 50(9):1601-1605
Web of Science PubMed FullText FullText_MUG

 

2011

Egberts, F; Gutzmer, R; Ugurel, S; Becker, JC; Trefzer, U; Degen, A; Schenck, F; Frey, L; Wilhelm, T; Hassel, JC; Schadendorf, D; Livingstone, E; Mauch, C; Garbe, C; Berking, C; Rass, K; Mohr, P; Kaehler, KC; Weichenthal, M; Hauschild, A Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma: a multicenter phase II DeCOG trial.
Ann Oncol. 2011; 22(7):1667-1674 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Hilgendorf, I; Eisele, S; Remer, I; Schmitz, J; Zeschky, K; Colberg, C; Stachon, P; Wolf, D; Willecke, F; Buchner, M; Zirlik, K; Ortiz-Rodriguez, A; Lozhkin, A; Hoppe, N; von zur Muhlen, C; zur Hausen, A; Bode, C; Zirlik, A The oral spleen tyrosine kinase inhibitor fostamatinib attenuates inflammation and atherogenesis in low-density lipoprotein receptor-deficient mice.
ARTERIOSCL THROM VAS. 2011; 31(9): 1991-1999. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Pinter, M; Sieghart, W; Hucke, F; Graziadei, I; Vogel, W; Maieron, A; Königsberg, R; Weissmann, A; Kornek, G; Matejka, J; Stauber, R; Buder, R; Grünberger, B; Schöniger-Hekele, M; Müller, C; Peck-Radosavljevic, M Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib.
Aliment Pharmacol Ther. 2011; 34(8): 949-959. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2009

Schulman, S; Kearon, C; Kakkar, AK; Mismetti, P; Schellong, S; Eriksson, H; Baanstra, D; Schnee, J; Goldhaber, SZ; RE-COVER Study Group Dabigatran versus warfarin in the treatment of acute venous thromboembolism.
N Engl J Med. 2009; 361(24):2342-2352 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2008

Hauschild, A; Trefzer, U; Garbe, C; Kaehler, KC; Ugurel, S; Kiecker, F; Eigentler, T; Krissel, H; Schott, A; Schadendorf, D Multicenter phase II trial of the histone deacetylase inhibitor pyridylmethyl-N-{4-[(2-aminophenyl)-carbamoyl]-benzyl}-carbamate in pretreated metastatic melanoma.
Melanoma Res. 2008; 18(4):274-278
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Hoffmann, K; Glimm, H; Radeleff, B; Richter, G; Heining, C; Schenkel, I; Zahlten-Hinguranage, A; Schirrmacher, P; Schmidt, J; Büchler, MW; Jaeger, D; von Kalle, C; Schemmer, P Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation - HeiLivCa [ISRCTN24081794].
BMC Cancer. 2008; 8(3):349-349 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2005

Balletshofer, BM; Goebbel, S; Rittig, K; Enderle, M; Schmölzer, I; Wascher, TC; Ferenc Pap, A; Westermeier, T; Petzinna, D; Matthaei, S; Häring, HU Intense cholesterol lowering therapy with a HMG-CoA reductase inhibitor does not improve nitric oxide dependent endothelial function in type-2-diabetes--a multicenter, randomised, double-blind, three-arm placebo-controlled clinical trial.
EXP CLIN ENDOCRINOL DIABETES 2005 113: 324-330.
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Eller, P; Pechlaner, C Roflumilast for chronic obstructive pulmonary disease.
Lancet. 2005; 366(9500): 1845-1846.
Web of Science PubMed FullText FullText_MUG

 

1982

Klein, W; Brandt, D; Fluch, N; Maurer, E Treatment of stable exercise angina with calcium blockers-a double-blind, placebo-controlled comparison of diltiazem and nifedipine
Z Kardiol. 1982; 71(6):398-405
Web of Science PubMed

 

© Med Uni Graz Impressum